Healthcare Decision Intelligence Market

Overview

The global Healthcare Decision Intelligence Market was valued at USD 9.6 billion in 2025 and is projected to reach USD 39.4 billion by 2034, growing at a CAGR of 17% during the forecast period (2026–2034). The market is driven by the need to turn fragmented clinical, operational and claims data into timely, explainable decisions at the bedside, in the command center and at the payer desk. Hospitals facing bed shortages, workforce gaps and shared-risk contracts are buying platforms that predict demand, rank next-best actions and track results, rather than static dashboards. The market is shifting from conventional, retrospective business intelligence reports toward predictive, generative and agent-based systems that sit inside the electronic health record and recommend an action at the moment a decision is made. Vendors are moving from selling single algorithms to selling governed platforms that host many models, monitor drift and bias, and keep clinicians in control. Government initiatives such as the US Food and Drug Administration's revised Clinical Decision Support Software guidance, issued on January 6, 2026, are giving developers clearer rules on which decision support functions remain outside device regulation. The revision removes much of the earlier language on time-critical decision-making and clarifies how single-recommendation tools are treated. Clearer boundaries shorten product planning cycles and encourage health systems to approve new decision tools faster. By Region, North America held the largest share of the market in 2025, accounting for 44% of global revenue, supported by early adoption of predictive AI in hospitals, value-based payment models and a deep base of healthcare technology vendors in the United States. Asia-Pacific is expected to be the fastest-growing region during the forecast period, led by national digital health programs in India and China, rapid hospital digitization in Japan and South Korea, and rising demand for analytics-led care.

Market Size & Share

Market Dynamics

KEY MARKET TREND

Foundation Models and Predictive AI Emerging as a Transformational Trend in Healthcare Decision-Making

• Health systems are moving from retrospective dashboards to predictive and prescriptive models that flag deterioration, readmission risk and capacity strain hours before they occur. This shift turns analytics from a monthly reporting exercise into a daily workflow tool. Care teams now open risk lists at every shift huddle and assign actions to named staff.
• Large language models and clinical foundation models are being trained on de-identified records, imaging and claims so users can ask questions in plain language. Vendors are embedding these models inside the electronic health record and operations platforms. Clinicians therefore receive recommendations without leaving the screens they already use, which speeds adoption and limits training needs.
• Competition is shifting toward platforms that govern many models in one place instead of selling a single algorithm. Buyers now ask for bias testing, drift monitoring and audit trails before approving any tool. This favors vendors that combine analytics, workflow integration and clinical validation in one offering, and it pushes smaller point-solution vendors toward partnerships.
• Epic announced its CoMET models in 2025, trained on more than 100 billion medical events from its Cosmos research database. In early testing across 78 evaluations, the models performed as well as or better than most single-task predictive models. Researchers at health systems participating in Cosmos were scheduled to gain access through a virtual lab from February 2026.

KEY MARKET DRIVER

Mounting Pressure on Hospital Capacity, Staffing and Margins Is Driving Adoption of Decision Intelligence

• Hospitals face persistent bed shortages, workforce gaps and thin operating margins, so leaders need faster ways to place patients, schedule staff and release capacity. Decision intelligence platforms convert live admission, discharge and staffing data into ranked actions. This cuts avoidable waiting and boarding time and gives executives a measurable way to protect revenue.
• The move to value-based payment raises the cost of poor decisions. Providers and payers need risk stratification, care gap closure and contract modeling to protect performance under shared-risk agreements. Analytics budgets are therefore shifting from retrospective reporting toward tools that trigger a specific action, assign an owner and record the financial result.
• Electronic health records, claims, imaging and device feeds now produce more information than clinicians can review by hand. Platforms that unify these sources and surface the next best step have become a practical necessity. The need is greatest in chronic disease management and critical care, where small delays in recognizing risk lead to costly complications.
• The US Assistant Secretary for Technology Policy reported that 71% of non-federal acute care hospitals used predictive AI integrated with their electronic health record in 2024, up from 66% in 2023. Hospitals sourced most of these models from their EHR developer. This shows steady demand for embedded decision tools and a rising baseline of buyer experience.

KEY MARKET OPPORTUNITY

Outcome-Linked Subscription Models and Care Setting Expansion Creating New Revenue Streams

• Vendors are packaging decision intelligence as subscriptions with pricing tied to measured results, such as released bed days or added surgical cases. This lowers the entry barrier for hospitals with tight capital budgets. It also gives suppliers recurring revenue with stronger customer retention and a clear story for finance committees reviewing return on investment.
• Community, rural and independent hospitals remain under-served because they lack in-house data science teams. Cloud-hosted, pre-built models that connect to an existing health record offer a low-effort starting point. This opens a large pool of new buyers beyond academic medical centers and rewards vendors that can implement quickly with minimal local staff.
• Payers and life sciences companies are adopting patient-journey data and actuarial models for contract design, network planning and launch decisions. Health systems that once bought only clinical tools are now buying finance and population health intelligence. This widens the revenue pool for each vendor and creates cross-selling room between provider, payer and drug developer customers.
• Qventus raised USD 105 million in a Series D round led by KKR in January 2025, with Bessemer Venture Partners and the health systems Northwestern Medicine, HonorHealth and Allina Health joining as investors. The company said the funding would extend its AI operational assistants into new care settings beyond its surgical and inpatient solutions.

Healthcare Decision Intelligence Market Size, 2025-2034 (USD Billion)

Segmentation Analysis

Analysis by Type

Decision Support held the largest market share in 2025 because most health systems begin their decision intelligence journey with tools that inform a clinician or manager and leave the final call with a person. Alerts, risk scores, dashboards and evidence-based recommendations embedded in the health record are easy to approve, quick to deploy and familiar to clinical committees. Governance teams are comfortable with these tools because every output can be reviewed and overridden. Regulatory guidance that favors human review of recommendations has kept decision support at the center of hospital purchasing, and a large installed base of clinical knowledge and analytics products keeps renewal rates high.

Decision Augmentation is projected to grow at the fastest CAGR during the forecast period as generative AI and foundation models move from experiments into daily workflows. Augmentation tools draft summaries, propose orders, rank patient lists and explain the reasoning behind a recommendation, which saves clinician time without removing accountability. Health systems struggling with burnout and staffing gaps see a direct return from tools that shorten chart review and prioritize work. Vendors are adding model monitoring, citation of source evidence and role-based controls, which improves trust and speeds approval of new use cases across clinical, operational and financial teams.

Type categories include

                   ·           Decision Support (Dominating Segment)

                   ·           Decision Augmentation (Highest CAGR Segment)

                   ·           Decision Automation

Analysis by Component

Software held the largest market share in 2025 because the core value of decision intelligence sits in platforms, analytics engines, prediction models and workflow applications that health systems license on a recurring basis. Providers prefer products that connect directly to the electronic health record, scheduling, staffing and claims systems, and that offer pre-built healthcare data models and ready-to-use content. Subscription contracts create predictable revenue for vendors, while frequent model updates and new modules encourage customers to expand their footprint. Purchasing teams also favor software because it can be validated, audited and scaled across hospitals with limited additional staffing.

Services are projected to grow at the fastest CAGR during the forecast period as health systems realize that software alone does not change outcomes. Implementation, data engineering, clinical change management, model validation and managed analytics support are in high demand because many hospitals lack data science staff. Buyers increasingly prefer vendors that stay accountable for measurable results, such as shorter length of stay or improved quality scores, and are willing to sign multi-year managed service agreements. Growing attention to AI governance and local model testing adds a further layer of advisory and monitoring work.

Component categories include

                   ·           Software (Dominating Segment)

                   ·           Services (Highest CAGR Segment)

Analysis by Deployment Mode

Cloud-Based deployment held the largest market share in 2025 because it gives hospitals fast access to scalable computing, regular model updates and shared benchmarking data without large capital spending. Health systems adopting generative AI and foundation models need elastic processing capacity that on-site servers rarely provide. Cloud delivery also shortens implementation timelines, supports remote access for multi-hospital networks and simplifies integration with partner data sources. Major healthcare cloud providers now offer compliance controls aligned with health privacy rules, which has reduced security concerns among hospital boards and chief information officers who once preferred to keep analytics workloads in their own data centers.

Hybrid deployment is projected to grow at the fastest CAGR during the forecast period as organizations look for a balance between data control and advanced AI capability. Hospitals in regulated markets often keep patient-level records in local environments for privacy and data residency reasons, while sending de-identified data to the cloud for model training and heavy analytics. This approach satisfies legal teams without giving up access to modern tools. Vendors are responding with containerized models, federated learning and edge processing that let predictions run near the point of care while governance and updates are managed centrally.

Deployment Mode categories include

                   ·           Cloud-Based (Dominating Segment)

                   ·           On-Premises

                   ·           Hybrid (Highest CAGR Segment)

Analysis by Application

Clinical Decision Support held the largest market share in 2025 because safer, more consistent care is the strongest argument for investment, and clinical leaders can link these tools directly to quality, patient safety and malpractice risk. Drug interaction checks, sepsis and deterioration alerts, diagnostic support and evidence-based order sets are already built into most electronic health records, creating a broad base of users. Hospital accreditation programs and quality reporting requirements reward standardized practice, which keeps spending steady. New generative AI assistants are extending the category from alerts into conversational answers at the point of care.

Operations Management is projected to grow at the fastest CAGR during the forecast period as hospitals confront bed shortages, long emergency department waits and costly staffing imbalances. Predictive tools that forecast admissions, discharges and surgical demand, and then recommend specific actions, deliver measurable savings within months, which makes them easier to fund than purely clinical projects. Command center models, AI operational assistants and automated discharge planning are spreading from large academic centers to regional systems. Chief financial officers favor these tools because results can be tracked through length of stay, throughput and operating room utilization.

Application categories include

                   ·           Clinical Decision Support (Dominating Segment)

                   ·           Operations Management (Highest CAGR Segment)

                   ·           Population Health Management

                   ·           Revenue Cycle Management

                   ·           Supply Chain Management

Analysis by End User

Healthcare Providers held the largest market share in 2025 because hospitals and health systems generate the data, face the daily pressure of capacity and staffing, and carry the clinical accountability that decision tools are designed to support. They run the largest number of use cases, from bedside risk scoring to scheduling and discharge coordination, and they hold the budgets for enterprise platforms. Margin pressure, nurse shortages and quality-based reimbursement keep leadership focused on measurable improvement. Large multi-hospital systems also have the data teams needed to deploy, validate and govern these tools, which speeds adoption.

Payers are projected to grow at the fastest CAGR during the forecast period as health plans use decision intelligence to manage medical costs, risk adjustment, utilization review and provider network design. Shared-risk and value-based contracts require accurate forecasting of member risk and provider performance, which favors advanced analytics. Plans are also automating prior authorization and claims review, where predictive models reduce manual effort and shorten response times. Growing cooperation between payers and providers on shared data platforms further increases demand for tools that translate patient-journey information into specific actions, and plans with strong analytics teams can negotiate better provider contracts.

End User categories include

                   ·           Healthcare Providers (Dominating Segment)

                   ·           Payers (Highest CAGR Segment)

                   ·           Life Sciences Companies

                   ·           Government Agencies

By Region

Healthcare Decision Intelligence Market Regional Analysis

Healthcare Decision Intelligence Market Share 2025, (CAGR)

North America

44%

South America

XX%

Europe

24%

Middle East Africa

XX%

Asia Pacific

XX%

Regional Analysis

North America held the largest market share in 2025, supported by early adoption of predictive AI in hospitals, value-based payment programs and a deep base of healthcare technology vendors. The United States leads the region, with large health systems using command centers, risk models and AI assistants inside the electronic health record, while federal agencies have been refining their approach to clinical decision support software oversight. Canada is investing in provincial digital health records and analytics for wait-time reduction, and Mexico is expanding private hospital digitization. Competition is intense, with electronic health record vendors, specialist analytics firms and technology companies all targeting the same hospital budgets, and partnerships between them are common.

Asia-Pacific is projected to grow at the fastest CAGR during the forecast period, driven by expanding digital healthcare infrastructure, increasing healthcare expenditure, and rising demand for data-driven clinical and operational decisions. China is advancing healthcare digitalization and AI-assisted diagnosis, while India is expanding digital health infrastructure through the Ayushman Bharat Digital Mission and the integration of electronic health records. Japan is adopting healthcare analytics to address its aging population and growing long-term care needs, while South Korea is investing in digital hospitals and AI-enabled medical services. Across the region, healthcare providers are increasingly using data analytics to improve diagnosis, resource allocation, patient management, and treatment planning. These developments are expected to accelerate demand for healthcare decision intelligence solutions.

Countries and Regions Covered

Asia-Pacific (Fastest Growing Region)

o   China (Largest Country Market)

o   India (Fastest-Growing Country Market)

o   Japan

o   South Korea

o   Rest of Asia-Pacific

North America (Dominating Region)

o   United States (Largest Country Market)

o   Canada

o   Mexico

Europe

o   Germany (Largest Country Market)

o   France

o   United Kingdom

o   Italy

o   Rest of Europe

Latin America

o   Brazil (Largest Country Market)

o   Chile (Fastest-Growing Country Market)

o   Rest of Latin America

Middle East & Africa

o   Saudi Arabia (Largest Country Market)

o   United Arab Emirates (Fastest-Growing Country Market)

o   Rest of Middle East & Africa

Market Share

The Healthcare Decision Intelligence Market is fragmented. Electronic health record vendors, enterprise software groups, imaging and medical technology firms, clinical knowledge publishers and venture-backed analytics specialists all compete for the same hospital and payer budgets, and no single supplier holds a dominant share across every application. Success depends on clinical credibility, deep integration with the health record, proof of measurable outcomes and strong model governance. Leading companies are prioritizing foundation model development, acquisitions that extend capabilities across the patient journey, and partnerships with cloud and data platform providers. Capacity management and patient flow specialists are consolidating adjacent workflows, while knowledge publishers are adding generative AI to trusted clinical content to protect their position with hospitals.

Key Players

                   ·           Palantir Technologies Inc. (US)

                   ·           Oracle Corporation (US)

                   ·           Optum, Inc. (US)

                   ·           GE HealthCare Technologies Inc. (US)

                   ·           Koninklijke Philips N.V. (Netherlands)

                   ·           Wolters Kluwer N.V. (Netherlands)

                   ·           Elsevier B.V. (Netherlands)

                   ·           Merative L.P. (US)

                   ·           Health Catalyst, Inc. (US)

                   ·           Innovaccer Inc. (US)

                   ·           Komodo Health, Inc. (US)

                   ·           LeanTaaS, Inc. (US)

                   ·           Qventus, Inc. (US)

                   ·           TeleTracking Technologies, Inc. (US)

                   ·           Aidoc Medical Ltd. (Israel)

Recent Market Developments

• In September 2025, Wolters Kluwer Health launched UpToDate Expert AI, a generative AI clinical decision support solution built on UpToDate's expert-authored content and designed for enterprise-wide deployment inside electronic health records and AI scribes. The launch shows established clinical knowledge publishers moving into governed generative AI, raising competitive pressure on newer entrants.
• In April 2026, Aidoc raised USD 150 million in a Series E round led by Growth Equity at Goldman Sachs Alternatives to expand its CARE clinical foundation model and aiOS platform. The company said CARE had earlier in 2026 received the first FDA clearance for a foundation model-based triage system in clinical imaging, a milestone for regulated foundation model products.
• In September 2026, LeanTaaS acquired Aidin, a care transition platform serving more than 200 hospitals and coordinating over two million referrals a year across 21,000 post-acute providers. Aidin's referral network will be built into iQueue for Inpatient Flow, linking discharge readiness with placement workflows and extending capacity intelligence beyond the hospital walls.
• In September 2026, GE HealthCare introduced CareIntellect for Operations, an AI-enabled software-as-a-service application that forecasts capacity constraints up to 72 hours ahead at unit, department and enterprise level. Built on experience from its Command Center software, used by nearly 500 hospitals, it is first being implemented at The Queen's Health Systems and Duke Health.

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What is Healthcare Decision Intelligence?

2

What is the CAGR of the Healthcare Decision Intelligence Market?

3

Which type leads the Healthcare Decision Intelligence Market?

4

Which application dominates the Healthcare Decision Intelligence Market?

5

Which deployment mode has the highest market share?

6

What are the latest trends in the Healthcare Decision Intelligence Market?

7

Who are the end users of Healthcare Decision Intelligence?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates